Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

5.0%

1 terminated out of 20 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

20%

4 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results86% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (9)
P 1 (1)
P 2 (3)
P 3 (3)
P 4 (1)

Trial Status

Recruiting7
Completed6
Unknown3
Enrolling By Invitation1
Not Yet Recruiting1
Terminated1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT07477626Phase 3Active Not Recruiting

Radiotherapy After Prostatectomy for Node Positive Prostate Cancer

NCT06957691Phase 2Recruiting

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

NCT06130995Phase 1RecruitingPrimary

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

NCT05700903Phase 4CompletedPrimary

Contributions to Hypertension With Androgen Deprivation Therapy

NCT06972875Phase 2Recruiting

Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

NCT07335224Not ApplicableRecruiting

Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture

NCT05327465Not ApplicableRecruitingPrimary

Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy

NCT07134439Not Yet Recruiting

Identifying Fundamental Mechanisms of Skeletal Muscle Ageing in Older Men Undergoing Androgen Deprivation Therapy: a Feasibility Study

NCT07032584Not ApplicableRecruiting

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

NCT06872619Enrolling By Invitation

RegisterPROS - a Registry for Prostate Cancers

NCT03867357Completed

Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia

NCT05781217Phase 3Recruiting

Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

NCT03440879Not ApplicableTerminated

Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose

NCT03845751Phase 2Unknown

EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.

NCT04500080Not ApplicableCompleted

Feasibility and Safety of Physical Exercise in Men With Prostate Cancer

NCT03672396Not ApplicableCompleted

Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer

NCT04062162Not ApplicableUnknown

Walking Football as a Supportive Medicine for Patients With Prostate Cancer

NCT02631681Not ApplicableCompleted

Supervised Group Based Exercise for Men With Prostate Cancer on Androgen Deprivation Therapy

NCT01711892Not ApplicableCompleted

Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy

NCT00957606Phase 3Unknown

Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer

Showing all 20 trials

Research Network

Activity Timeline